Hosted by the International Society of Pharmacogenomics, the Pharmacogenomics E-Symposium will be held live & online on 12 December 2005. This online event is cutting edge and rich in knowledge with keynotes by Allen Roses from GlaxoSmithKline and Urs Meyer at the Biozentrum, University of Basel and exciting round table debates featuring the world's leading experts from academia, government and industry.
(PRWEB) December 7, 2005 -- The International Society of Pharmacogenomics is hosting a ground-breaking Pharmacogenomics E-Symposium, http://www.pgx.e-symposium.com, and registration to this online event is free of charge.
The groundbreaking Pharmacogenomics E-Symposium™ will be broadcast live and online on 12 December 2005 and archived thereafter.
"With personalised medicine gaining momentum, it is vital for a truly global dialogue to develop and we believe that the E-Symposium will stimulate indispensable knowledge sharing amongst academia, government and industry.", says Prof. Julio Licinio, President of the International Society of Pharmacogenomics and also Editor of the Pharmacogenomics Journal and Co-Director of the PGx Laboratory at UCLA.
The online nature of the event means that all delegates will be able to tune in and listen to leading scientists and experts from the convenience of their own workplace and share knowledge with colleagues internationally.
The E-Symposium is broadcast via cutting edge webcasting technology which is accessible to anyone with a computer, a soundcard and an Internet connection.
Registration is free to all, www.pgx.e-symposium.com.
Program Highlights:
Opening Keynote: Allen Roses, GlaxoSmithKline
Live Presentations and Round table debates on:
-Pharmacogenomics : Delivery to patients and patient acceptance
-Prescribing by ethnicity
-What is the role of pharmacogenomics in our approaches to substance abuse?
-The role of Pharmacogenomics as a laboratory tool in diagnostics and therapeutics
-Toxicogenomics - Is the Problem the Toxin or the Genome?
-Cancer Pharmacogenomics
-Cardiovascular Pharmacogenomics
-Pharmacogenomics of Psychiatry
-Pharmacogenomics of Neurological Disorders
and more.
Closing Keynote: Urs Meyer, Biozentrum, University of Basel
Advisory Committee
Julio Licinio
[President, International Society of Pharmacogenomics Co-Director of the Laboratory for Pharmacogenomics & Professor of Psychiatry & Biobehavioral Sciences and Medicine/Endocrinology, UCLA Editor, The Pharmacogenomics Journal
Adrián Llerena
[Department of Pharmacology and Psychiatry, Faculty of Medicine, University of Extremadura, Spain
Dr. Werner Kalow
[Professor Emeritus, University of Toronto
Review Committee
Junichi Azuma
[Clinical Evaluation of Medicines and Therapeutics, Graduate School of Pharmaceutical Sciences, Osaka University
Andrew Dillon CBE
[Chief Executive, National Institute for Clinical Excellence (NICE), NHS
Dr Howard McLeod
[Associate Professor of Medicine, Washington University
Julia Kirchheiner
[Group Leader, Clinical Pharmacogenetics Working Group, Department of Pharmacology, University of Köln
Leena Peltonen-Palotie
[Academy Professor, Department of Medical Genetics, University of Helsinki, Department of Molecular Medicine, National Public Health Institute, The Broad Institute, MIT Boston, Biomedicum Helsinki, Finland
###
|
